RecruitingNCT05596539

Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia (REG-HYPO)

Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

130 participants

Start Date

Mar 22, 2023

Study Type

OBSERVATIONAL

Conditions

Hypophosphatasia

Summary

The purpose of this study is to assess medical events during follow-up of adult patients having hypophosphatasia and consulting rheumatologists.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Data collection for people with hypophosphatasia. The study is currently recruiting participants at 11 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERData collection

Collection data from diagnostic Data collected following to medical exam as part of care

Locations(11)

CHU de Bordeaux- Hôpital Pellegrin Place Amélia Raba Léon - 12è étage - Rhumatologie -

Bordeaux, France, France

CHU Lille

Lille, France

Hospices Civils de Lyon

Lyon, France

CHU Nice

Nice, France

Lariboisière Hospital

Paris, France

Cochin Hospital

Paris, France

CHU Poitiers

Poitiers, France

CHU Rennes

Rennes, France

CHU Saint-Etienne

Saint-Priest-en-Jarez, France

Les hôpitaux universitaires de Strasbourg

Strasbourg, France

CHU de Toulouse

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05596539

Related Trials

The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in Russia

NCT073902404 locations

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT017931682 locations